Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jennifer Mosse"'
Autor:
Teagan Guarnaccia, Louise A Carolan, Sebastian Maurer-Stroh, Raphael T C Lee, Emma Job, Patrick C Reading, Stephen Petrie, James M McCaw, Jodie McVernon, Aeron C Hurt, Anne Kelso, Jennifer Mosse, Ian G Barr, Karen L Laurie
Publikováno v:
PLoS Pathogens, Vol 9, Iss 5, p e1003354 (2013)
Surveillance data indicate that most circulating A(H1N1)pdm09 influenza viruses have remained antigenically similar since they emerged in humans in 2009. However, antigenic drift is likely to occur in the future in response to increasing population i
Externí odkaz:
https://doaj.org/article/936900b197b44da8b5fa6b2036e8623e
Publikováno v:
Conservation Genetics. 19:713-728
In the Australian state of Victoria, the history of koalas and their management has resulted in the homogenisation and reduction of genetic diversity in many contemporary populations. Decreased genetic diversity may reduce a species’ ability to ada
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e013988c1b0c4f24ea5ab14bb033bbf2
https://doi.org/10.1007/s10592-018-1049-8
https://doi.org/10.1007/s10592-018-1049-8
Publikováno v:
Conservation Genetics Resources. 11:219-229
Genetic sampling from faeces is a useful method for obtaining DNA samples non-invasively. The quantity and quality of DNA isolated from faecal samples is, however, an important factor affecting the success of downstream analyses. Commercial DNA isola
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e02c62051444349cfeeb0b7aef4d21f
https://doi.org/10.1007/s12686-018-0994-3
https://doi.org/10.1007/s12686-018-0994-3
Autor:
Rubaiyea Farrukee, Jacqueline Panozzo, Sophie Vitesnik, David Piedrafita, Ding Yuan Oh, Jennifer Mosse, Aeron C. Hurt
Publikováno v:
Antiviral Therapy. 23:295-306
Background Intravenous zanamivir has been used to treat patients with severe influenza. Because the majority of cases (including immunocompromised patients) require the drug for an extended period of treatment, there is a higher risk that the virus w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeee348a560814d67bf57c32b6ac0666
https://doi.org/10.3851/imp3135
https://doi.org/10.3851/imp3135
Publikováno v:
Conservation Genetics Resources. 8:511-521
Pathogenic diseases may threaten the viability of wild animal populations, especially when already vulnerable. The mitigation of risks associated with pathogenic infections in populations is an important factor in conservation strategies. Koalas are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a08d933f6743f07a9561127ea507fd8
https://doi.org/10.1007/s12686-016-0574-3
https://doi.org/10.1007/s12686-016-0574-3
Publikováno v:
Wildlife Research. 45:366
Context Pathogenic infections are an important consideration for the conservation of native species, but obtaining such data from wild populations can be expensive and difficult. Two pathogens have been implicated in the decline of some koala (Phasco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b17f0ea735a6a30bb65760b42fe34cc4
https://doi.org/10.1071/wr17184
https://doi.org/10.1071/wr17184
Autor:
Anne Kelso, Steve Rockman, Ian G. Barr, Teagan Guarnaccia, Karen L. Laurie, Kathryn Borg, Jennifer Mosse, Louise A. Carolan, Patrick C. Reading
Publikováno v:
Journal of virology. 90(6)
The burden of infection with seasonal influenza viruses is significant. Each year is typically characterized by the dominance of one (sub)type or lineage of influenza A or B virus, respectively. The incidence of disease varies annually, and while thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d790a8f00740268b3e2babd95a51fd0f
https://pubmed.ncbi.nlm.nih.gov/26719259
https://pubmed.ncbi.nlm.nih.gov/26719259
Autor:
Kenneth Margo, Aeron C. Hurt, Ding Yuan Oh, David Alexander Vodden Morton, David Piedrafita, Jennifer Mosse, Jacqueline Panozzo
Publikováno v:
Antiviral research. 120
Laninamivir is a long-acting antiviral requiring only a single dose for the treatment of influenza infection, making it an attractive alternative to existing neuraminidase inhibitors that require multiple doses over many days. Like zanamivir, laninam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d4861619cb085104332569ea0dea178
https://pubmed.ncbi.nlm.nih.gov/26022199
https://pubmed.ncbi.nlm.nih.gov/26022199